Enovis (ENOV) Amortization of Deferred Charges (2010 - 2026)
Enovis' (ENOV) quarterly Amortization of Deferred Charges came in at $1.8 million in Q2 2026, up 32.64% year-on-year from $1.3 million in Q2 2025, and down 20.81% on a QoQ basis from $2.3 million in Q4 2025.
Enovis (ENOV) Amortization of Deferred Charges (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 16 years of Amortization of Deferred Charges data on file, last reported at $1.8 million in Q2 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 32.64% year-over-year to $1.8 million in Q2 2026; TTM through Apr 2026 was $7.8 million, a 45.4% increase from a year earlier, with the FY2025 full-year figure at $7.4 million, up 39.89% from the prior year.
- Amortization of Deferred Charges for Q2 2026 stood at $1.8 million, down from $2.3 million in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for ENOV reached as high as $2.3 million in Q4 2025 and fell as low as $625000.0 in Q4 2023.
- Historically, Amortization of Deferred Charges has averaged $1.3 million across 5 years, with a median of $1.3 million in 2024.
- Across the five-year window, Amortization of Deferred Charges slumped 53.34% in 2023 and jumped 177.6% in 2024, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $900000.0 in 2022, then slumped by 30.56% to $625000.0 in 2023, then jumped by 177.6% to $1.7 million in 2024, then jumped by 30.14% to $2.3 million in 2025, then slipped by 20.81% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $1.8 million in Q2 2026, $2.3 million in Q4 2025, and $1.9 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.30 Bn | 175.00 Bn | 6.27 Bn |
| 2 | Stryker | 128.77 Bn | 125.89 Bn | 3.81 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.85 Bn | 66.39 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.12 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.98 Bn | 25.70 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.78 Bn | 20.65 Bn | 2.07 Bn |
| 10 | Enovis | 1.62 Bn | 1.58 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 1.79 Mn |
| Apr 3, 2026 | 1.79 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Dec 31, 2025 | 2.26 Mn |
| Oct 3, 2025 | 1.92 Mn |
| Oct 3, 2025 | 1.92 Mn |
| Jul 4, 2025 | 1.86 Mn |
| Jul 4, 2025 | 1.86 Mn |
| Apr 4, 2025 | 1.35 Mn |
| Apr 4, 2025 | 1.35 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 27, 2024 | 981,000.00 |
| Sep 27, 2024 | 981,000.00 |
| Jun 28, 2024 | 1.31 Mn |
| Jun 28, 2024 | 1.31 Mn |
| Mar 29, 2024 | 1.25 Mn |
| Mar 29, 2024 | 1.25 Mn |
| Dec 31, 2023 | 625,000.00 |
| Dec 31, 2023 | 625,000.00 |